Diagnostic value of contrast-enhanced ultrasound for sentinel lymph node metastasis in breast cancer: an updated meta-analysis

Liu, Xiao; Wang, Meihuan; Wang, Qian; Zhang, Huawei

doi:10.1007/s10549-023-07063-2

Breast Cancer Res Treat

2023

DOI: 10.1007/s10549-023-07063-2

|View full text |Cite

Diagnostic value of contrast-enhanced ultrasound for sentinel lymph node metastasis in breast cancer: an updated meta-analysis

Xiao Liu¹,

Meihuan Wang²,

Qian Wang³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

2024

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 6 publications

References 46 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Prospects of perfusion contrast-enhanced ultrasound (CE-US) in diagnosing axillary lymph node metastases in breast cancer: a comparison with lymphatic CE-US

Mori,

Li,

Matsuda

et al. 2024

J Med Ultrasonics

View full text Add to dashboard Cite

Accurate diagnosis of lymph node (LN) metastasis is vital for prognosis and treatment in patients with breast cancer. Imaging 1modalities such as ultrasound (US), MRI, CT, and 18F-FDG PET/CT are used for preoperative assessment. While conventional US is commonly recommended due to its resolution and sensitivity, it has limitations such as operator subjectivity and difficulty detecting small metastases. This review shows the microanatomy of axillary LNs to enhance accurate diagnosis and the characteristics of contrast-enhanced US (CE-US), which utilizes intravascular microbubble contrast agents, making it ideal for vascular imaging. A significant focus of this review is on distinguishing between two types of CE-US techniques for axillary LN evaluation: perfusion CE-US and lymphatic CE-US. Perfusion CE-US is used to assess LN metastasis via transvenous contrast agent administration, while lymphatic CE-US is used to identify sentinel LNs and diagnose LN metastasis through percutaneous contrast agent administration. This review also highlights the need for future research to clarify the distinction between studies involving “apparently enlarged LNs” and “clinical node-negative” cases in perfusion CE-US research. Such research standardization is essential to ensure accurate diagnostic performance in various clinical studies. Future studies should aim to standardize CE-US methods for improved LN metastasis diagnosis, not only in breast cancer but also across various malignancies.

show abstract

Prospects of perfusion contrast-enhanced ultrasound (CE-US) in diagnosing axillary lymph node metastases in breast cancer: a comparison with lymphatic CE-US

Mori,

Li,

Matsuda

et al. 2024

J Med Ultrasonics

View full text Add to dashboard Cite

show abstract

Percutaneous and intravenous contrast material injection in contrast-enhanced ultrasound for sentinel lymph node evaluation in patients with breast cancer: importance of discussing difference in purposes

Mori

2023

Breast Cancer Res Treat

View full text Add to dashboard Cite

Lymph node metastasis in cancer: Clearing the clouds to see the dawn

Li,

Zhou,

et al. 2024

Critical Reviews in Oncology/Hematology

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Diagnostic value of contrast-enhanced ultrasound for sentinel lymph node metastasis in breast cancer: an updated meta-analysis

Cited by 6 publications

References 46 publications

Prospects of perfusion contrast-enhanced ultrasound (CE-US) in diagnosing axillary lymph node metastases in breast cancer: a comparison with lymphatic CE-US

Prospects of perfusion contrast-enhanced ultrasound (CE-US) in diagnosing axillary lymph node metastases in breast cancer: a comparison with lymphatic CE-US

Percutaneous and intravenous contrast material injection in contrast-enhanced ultrasound for sentinel lymph node evaluation in patients with breast cancer: importance of discussing difference in purposes

Lymph node metastasis in cancer: Clearing the clouds to see the dawn

Contact Info

Product

Resources

About